Accuracy Coverage Pricing Contact

Vectura confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme

Investment Tools Ltd.
Vectura confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme

The Vectura Board has announced a proposed special dividend of approximately £40m to be accompanied by a share consolidation, both subject to shareholder approval, with a £10m on-market share buyback to commence following the share consolidation. The Board also intends to undertake a further on-market £10m buyback, to be announced in due course after the completion of the first tranche.

Other financial highlights include:

Total revenue of £91.7m, +14.8%

o Product supply revenue up 42.9% to £54.3m, driven by 45.8% growth in flutiform® product supply chain revenues to £48.4m 

o As expected, royalty and other marketed revenue down 16.5% to £30.3m, following Q3 2018 expiry of EXPAREL® patents and a one-off milestone recognised in the prior period

o Development revenue up 26.8% to £7.1m, including EU filing milestone of $2.5m for QVM149

Gross profit declined by 1.3% compared to the prior period, impacted by normalisation of flutiform® supply chain margins and reduction in royalty and other marketed revenue

R&D costs of £24.5m reduced 9.9% versus prior period

Adjusted EBITDA of £25.1m, up 10.6% versus the prior period

Operating loss of £14.1m down from a loss of £30.2m in the prior period, as a result a lower charge for amortisation of intangible assets

Strong liquidity maintained with closing cash and cash equivalents of £105.9m

Awarded $89.7m in damages by trial jury for the infringement of the relevant asserted claim of Vectura's US patent by US sales of three of GlaxoSmithKline's (GSK) Ellipta® products for the period from August 2016 through December 2018. Outcome of post-trial applications from both sides awaited. GSK has the right to appeal

VR315 (US) progressing as planned, submission of the CRL response expected Q4 2019 

Companies mentioned

Latest News

Investment Tools Limited

In line with their dividend policy, 3i Group will pay a first FY2020 dividend of 17.5 pence, which is 50% of their total FY2019 dividend. This first FY2020 dividend will be paid to shareholders on 8 January 2020.

Read more
Investment Tools Limited

The Board has approved an interim dividend of 16.57p per ordinary share ($1.0673 per American Depositary Share). This represents 35% of the total dividend per share of 47.34p in respect of the last financial year to 31 March 2019 and is in line with the Group's dividend policy. The interim dividend is expected to be paid on 15 January 2020 to shareholders on the register as at 29 November 2019.

Read more
Investment Tools Limited

NextEnergy Solar Fund Limited has announced an interim dividend of 1.7175 pence per Ordinary Share for the quarter ending 30 September 2019. The interim dividend of 1.7175 pence will be paid on 31 December 2019 to shareholders on the register as at the close of business on 22 November 2019. The ex-dividend date is 21 November 2019.

Read more
Investment Tools Limited

Regional REIT will pay a dividend of 1.90 pence per share ("pps") for the period 1 July 2019 to 30 September 2019, an increase of c. 3% (1 July 2018 to 30 September 2018: 1.85pps). The dividend payment will be made on 19 December 2019 to shareholders on the register as at 22 November 2019. The ex-dividend date will be 21 November 2019. The entire dividend will be paid as a REIT property income distribution ("PID").

Read more
Investment Tools Limited

Mediclinic International have declared an interim dividend per share that is maintained at 3.20 pence (1H19: 3.20 pence), with the Group applying its full-year dividend policy of 25% to 35% of adjusted earnings per share.

Read more
Investment Tools Limited

The Great Portland Board has declared an interim ordinary dividend of 4.7 pence per share (2018: 4.3 pence) which will be paid on 2 January 2020. All of this dividend will be a REIT Property Income Distribution (PID) in respect of the Group's tax-exempt property rental business.

Read more
Investment Tools Limited

The Prime People Board will be declaring an interim dividend of 1.80p per share (2019: 1.80p) payable on 6 December 2019 to those shareholders on the register on 22 November 2019.

Read more
Investment Tools Limited

In recent years, Stobart's dividend has been largely funded from the sale of assets rather than operational cash generation. The Board believes that this practice is unsustainable and no longer in the interest of shareholders. Whilst the Group continues to hold a significant portfolio of non-strategic infrastructure assets, the Board, will continue to sell assets in such a way that optimises the value to the Group. 

Read more
Investment Tools Limited

The interim dividend of 11.3p (last half year: 11.0p) per share has been approved by the Board of Directors after 28 September 2019. Accordingly, this dividend has not been recognised as a liability at the period end.

Read more
Investment Tools Limited

An interim dividend of 2.2p (H1 2019: 2.1p) will be paid on 7 February 2020 to shareholders on the register at 10 January 2020. The interim dividend represents one third of the prior year total dividend reflecting their previously communicated methodology. The full year dividend will be set in May.

Read more
More News